Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW November 21, 2022
Award will fund research into new metastatic prostate cancer therapies

Award will fund research into new metastatic prostate cancer therapies

Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Hutch News - October 21, 2022
New approach could make bone marrow transplantation safer, stronger

New approach could make bone marrow transplantation safer, stronger

Tests prevented relapse, limited GVHD in laboratory models of leukemia, multiple myeloma
Hutch News - October 14, 2022
Fred Hutchinson Cancer Center receives $710.5 million gift to accelerate cancer and infectious disease research

Fred Hutchinson Cancer Center receives $710.5 million gift to accelerate cancer and infectious disease research

The landmark gift from the Bezos family will fund multiple scientific priorities, including clinical trials support, new translational research capabilities and recruitment
News Releases - October 12, 2022
Making immunotherapy more effective against small cell lung cancer

Making immunotherapy more effective against small cell lung cancer

Human trial opens after experimental drug improves tumor growth suppression in mice
Hutch News - August 03, 2022
Vaccination after CAR-T-cell therapy

Vaccination after CAR-T-cell therapy

From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
Science Spotlight - December 20, 2021
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch News - December 18, 2020
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Hutch News - November 16, 2020
Fred Hutch completes move-in of Lake Union Steam Plant

Fred Hutch completes move-in of Lake Union Steam Plant

106,000-square-foot facility will be home to transformative data science and immunotherapy research aimed at faster cancer breakthroughs
News Releases - October 15, 2020
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results

Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results

'Practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
Hutch News - September 18, 2020
Last Modified, April 02, 2020